Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer have?
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer has 41 citations in the OpenAlex counts ScholarIQ stores.
When was Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer published?
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer?
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer?
The DOI for Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer is on the source record.
What is the PMID of Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer?
The PMID for Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer is on the source record.
What is the OpenAlex record for Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer?
The OpenAlex for Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer is on the source record.